Form 8-K - Current report:
SEC Accession No. 0001437749-25-013230
Filing Date
2025-04-28
Accepted
2025-04-28 07:58:02
Documents
17
Period of Report
2025-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250425_8k.htm   iXBRL 8-K 34145
2 EXHIBIT 5.1 ex_807584.htm EX-5.1 13617
3 EXHIBIT 10.1 ex_807380.htm EX-10.1 231409
8 hklogo35px.jpg GRAPHIC 8086
  Complete submission text file 0001437749-25-013230.txt   506863

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250428.xsd EX-101.SCH 4113
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250428_def.xml EX-101.DEF 13904
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250428_lab.xml EX-101.LAB 18374
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250428_pre.xml EX-101.PRE 13936
19 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250425_8k_htm.xml XML 5061
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 25875974
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)